Biosynthetic Gene-Based NoVel Diterpene Screening
methods described previously.23 A full-length cDNA sequence of
PaPS determined using RACE has been deposited in the DDBJ
database with accession code AB252833.
amygdali N2 was separated by silica gel column chromatography
(hexane/ethyl acetate ) 10:1). The fraction showing characteristic
1H NMR methyl signals like those of phomopsene was purified by
silica gel column chromatography (hexane/acetone ) 20:1), and
recrystallization from hexane/ethyl acetate afforded methyl pho-
mopsenonate (5.0 mg): colorless crystal; mp 151 °C; [R]25D 12° (c
0.50, CHCl3); UV λmax nm (ꢀ): 318 (370), 248 (17000). See Table
1 for 1H and 13C NMR data. IR νmax cm-1: 1731, 1718 (w), 1666;
EI-HR-MS (positive): calcd for C21H30O3 (M) 330.2195, found m/z
330.2199.
Functional Analysis for Cyclase. To amplify the ORF cDNAs
of PaPS, reverse transcriptase-polymerase chain reaction (RT-PCR)
was carried out using a set of primers, 5′-GGATCCGTCCAT-
CAACATTCATTCATCATG-3′ (sense, BamHI site underlined) and
5′-GCGGCCGCACACGACCCGACAGATCAGG-3′ (antisense,
Not I site underlined). For amplification of a cDNA fragment
encoding N347 mutant, another reverse primer was used: 5′-
GCGGCCGCCTAGGTAAGCTTGGTCACTTCG-3′ (antisense,
Not I site underlined and added stop codon in boldface type). Each
PCR product was digested with BamHI and Not I and ligated into
pGEX-4T-3 vector (Amersham Pharmacia) for expression as fusion
protein with GST at the N-terminus. The plasmid was transformed
into E. coli BL21trx. Procedures for growth of the E. coli cells,
induction of the gene expression, extraction and purification of
recombinant enzymes, and measurement of cyclase enzyme activity
were identical with those described previously.24 Twenty micro-
grams of GPP, FPP, or GGPP was used as the substrate with or
without IPP. Hydrocarbon products and dephosphorylated deriva-
tives from allylic diphosphates remained in the reaction mixture
were analyzed by GC-MS.24
Functional Analysis for Prenyltransferase. For amplification
of a cDNA fragment encoding C398 mutant, a set of primers were
used: 5′-GGATCCATGATGGTTGCTCGCATGAA-3′ (sense, Bam-
HI site underlined) and 5′-GTCGACCTAAACTTTGAGTAAGCT-
GA (antisense, SalI site underlined). PCR product was digested
with BamHI and SalI and subcloned into pQE30 vector (QIAGEN),
and the plasmid was transformed into E. coli BL21 (DE3). All
procedures following were the same as those described previously.25
Allylic substrates used were DMAPP, GPP, or FPP. The products
derived from allylic substrates with [14C]IPP were dephosphorylated
and subjected to reverse-phase TLC analysis using LKC-18
developed with acetone/H2O (9:1).
X-ray Analysis of Methyl Phomopsenonate (2).26The 0.33 ×
0.33 × 0.26 mm3 crystal was orthorhombic (P212121), a )
8.9881(7), b ) 13.7561(10), c ) 14.6616(11) Å, V ) 1812.8(2)
Å3, Z ) 4, and Dc ) 1.211 g/cm3. All diffraction intensities
with 2θ < 136.5° were collected at -180 °C in the ω-2θ scan
mode by a Rigaku RAXIS RAPID imaging plate area detector
with graphite monochromated Cu KR radiation (λ ) 1.54187
Å). Of the 8191 reflections collected, 1117 were unique, and
the structure was solved by direct methods (SIR92).27 The non-
hydrogen atoms were refined anisotropically. Hydrogen atoms
were refined isotropically. Full-matrix least-squares refinement
on F converged to a final Rw factor of 0.0280 and an R factor of
0.0245 for the 18,222 observed reflections (I > 2.00σ(I)).
(R)-r-Methoxy-r-trifluoromethylphenylacetate 4a. To a solu-
tion of methyl phomopsenonate (2, 20 mg, 0.061 mmol) and
CeCl3 · 7H2O (38 mg, 0.10 mmol) in methanol (0.2 mL) was
added NaBH4 (100 mg, 2.64 mmol) by portions at 0 °C. Acetone
(0.5 mL) was added, and the mixture was extracted with ethyl
acetate. The organic layers were dried over anhydrous Na2SO4
and concentrated in vacuo. The residue was purified by prepara-
tive TLC (hexane/ethyl acetate ) 8:1) giving the allylic alcohol
3. The product was unstable and was immediately used for the
next reaction. To a solution of 3 and (R)-MTPA (18 mg, 0.077
mmol) in CH2Cl2 (0.5 mL) were added dicyclohexylcarbodiimide
(62 mg, 0.30 mmol) and 4-(dimethylamino)pyridine (22 mg, 0.18
mmol). After standing at 25 °C for 12 h, the reaction mixture
was filtered through Celite and concentrated in vacuo. The
residue was purified by preparative TLC (hexane/ethyl acetate
) 6:1) affording the (R)-MTPA ester 4a (5 mg, 15% in 2 steps):
Extraction and Partial Purification of the Hydrocarbon
Fraction. The n-hexane extract was prepared in the usual way
from the samples of P. amygdali mycelia or E. coli cells. This
extract was loaded into a column packed with silica gel (BW-
820MH, Fuji Silysia Chemical). The column was eluted by
n-hexane, and the eluate was evaporated and subjected to
GC-MS analysis.
1
colorless oil; H NMR (400 MHz, CDCl3) δ 7.55 (2H, m), 7.42
Isolation of Phomopsene. Fermentation of P. amygdali N2 was
carried out at 25 °C on a reciprocal shaker for 3 days in two hundred
500-mL Sakaguchi flasks each containing 120 mL of medium of
5.0% glucose, 1.0% Pharmamedia (Southern Cotton Oil Inc.), 0.5%
KH2PO4, and 0.1% MgSO4. The mycelia were collected by filtration
and extracted with acetone. The acetone layer was concentrated in
vacuo, and the residual aqueous layer was adjusted to pH 9.5 with
5% aqueous Na2CO3. The resulting aqueous layer was extracted
with ethyl acetate, and the organic layers were concentrated in
vacuo. The ethyl acetate extract (11 g) was partitioned between
hexane and acetonitrile. The hexane layer was concentrated in
vacuo, and the residue (8 g) was purified by silica gel column
chromatography (hexane) twice giving the mixture of hydrocarbon
products (8 mg). This mixture was further separated by reverse-
phase HPLC (Develosil ODS UG-5, φ 10 × 250 mm, acetonitrile)
affording 1 (4 mg): colorless oil; [R]25D -97° (c 0.27, CHCl3). See
Table 1 for 1H and 13C NMR data. EI-HR-MS (positive): calcd for
C20H32 (M) 272.2504, found m/z 272.2505.
(3H, m), 5.66 (1H, m, H-8), 3.69 (3H, s, COOMe), 3.65 (3H, s,
OMe), 2.695 (1H, m, H-10), 2.443 (1H, dd, J ) 8.7, 10.7 Hz,
H-3), 2.288 (2H, broad, t, J ) 7.4 Hz, H-5), 2.10 (1H, m, H-4),
1.992 (1H, ddd, J ) 3.2, 4.9, 12.2 Hz, H-9b), 1.82 (1H, m, H-4),
1.594 (3H, s, H-17) 1.55 (1H, d, J ) 7.2 Hz, H-11), 1.47-1.35
(7H, m), 1.024 (3H, s), 1.016 (3H, s), 1.010 (3H, s); ESI-HR-
MS (positive): calcd for C31H39F3NaO5 (M + Na), 571.2647,
found m/z 571.2691.
(S)-r-Methoxy-r-trifluoromethylphenylacetate (4b). The (S)-
MTPA ester 4b was obtained with (S)-MTPA by using the
procedure just described for 4a. 4b: colorless oil; 1H NMR (400
MHz, CDCl3) δ 7.58 (2H, m), 7.41 (3H, m), 5.69 (1H, m, H-8),
3.70 (3H, s, COOMe), 3.61 (3H, s, OMe), 2.723 (1H, m, H-10),
2.473 (1H, dd, J ) 8.7, 10.5 Hz, H-3), 2.255 (2H, broad, t, J )
7.2 Hz, H-5), 2.10 (1H, m, H-4), 2.020 (1H, ddd, J ) 3.3, 4.9,
12.1 Hz, H-9b), 1.82 (1H, m, H-4), 1.553 (3H, s, H-17) 1.55
(1H, d, J ) 7.2 Hz, H-11), 1.47-1.33 (7H, m), 1.018 (3H, s),
1.013 (6H, s); ESI-HR-MS (positive): calcd for C31H39F3NaO5
(M + Na), 571.2647, found m/z 571.2661.
Isolation of Methyl Phomopsenonate (2). The mycelial ethyl
acetate extract (1.6 g) from 3.5 L of 6-day cultural broth of P.
(23) Toyomasu, T.; Kawaide, H.; Mitsuhashi, W.; Inoue, Y.; Kamiya, Y.
Plant Physiol. 1998, 118, 1517–1523.
(24) Otomo, K.; Kenmoku, H.; Oikawa, H.; Konig, W. A.; Toshima, H.;
Mitsuhashi, W.; Yamane, H.; Sassa, T.; Toyomasu, T. Plant J. 2004, 39, 886–
893.
(25) Kawasaki, T.; Hamano, Y.; Kuzuyama, T.; Itoh, N.; Seto, H.; Dairi, T.
J. Biochem. 2003, 133, 83–91.
(26) CCDC 703562 contains the supplementary crystallographic data for
data_request/cif, by emailing, or by contacting The Cambridge Crystal-
lographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, U.K.; fax +44
1223 336033.
J. Org. Chem. Vol. 74, No. 4, 2009 1547